Rockefeller Capital Management
MGNX icon

Rockefeller Capital Management’s MacroGenics MGNX Stock Holding History

Rockefeller Capital Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25
Closed -$40 – 4816
2025
Q4 		$40 Hold
25
– – ﹤0.01% 4648
2025
Q3 		$42 Buy
+25
New +$40 ﹤0.01% 4400

Other funds holding MGNX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Rockefeller Capital Management's MGNX Position: Q1 2026 in Review

Rockefeller Capital Management sold out of MacroGenics (MGNX) in Q1 2026, closing a stake of 25 shares — an estimated $40 sold.

Rockefeller Capital Management first reported a position in MGNX in Q3 2025 and held it in 2 quarters. The position peaked at $42 in Q3 2025. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

  • Rockefeller Capital Management reported no remaining MacroGenics position as of Q1 2026 after selling out during the quarter.
  • Rockefeller Capital Management sold 25 MacroGenics shares in Q1 2026, an estimated $40.
  • Rockefeller Capital Management first reported a position in MacroGenics in Q3 2025 and held it in 2 quarters.
  • Rockefeller Capital Management's MacroGenics position peaked at $42 in Q3 2025.
  • 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.